illicit drug markets in asia
play

Illicit drug markets in Asia: Focus on East and SE Asia - PowerPoint PPT Presentation

Illicit drug markets in Asia: Focus on East and SE Asia Presentation to 16 th ADEC, Tokyo Gary Lewis UNODC Regional Representative for East Asia and the Pacific 22 February 2010 Presentation Structure 1. Global situation 2. Amphetamine-Type


  1. Illicit drug markets in Asia: Focus on East and SE Asia Presentation to 16 th ADEC, Tokyo Gary Lewis UNODC Regional Representative for East Asia and the Pacific 22 February 2010

  2. Presentation Structure 1. Global situation 2. Amphetamine-Type Stimulants (focus on E/SE Asia) 3. Opiates • Afghanistan • Myanmar

  3. Presentation Structure 1. Global situation 2. Amphetamine-Type Stimulants (focus on E/SE Asia) 3. Opiates • Afghanistan • Myanmar

  4. Overview - Global • Containment is working  Opiates decline  Coca/cocaine declines  Drug use stabilizes in many countries  …but new warning signs  Shift away from opiates and cocaine towards ATS

  5. Overview – East and South-East Asia • ATS: Situation steadily worsening • Opiates: reversal of past successes

  6. Transnational Organized Crime Threat Assessment http://www.unodc.org/unodc/en/data-and-analysis/tocta-2010.html

  7. TOCTA: Key organized Crime Flows

  8. Presentation Structure 1. Global situation 2. Amphetamine-Type Stimulants (focus on E/SE Asia) 3. Opiates • Afghanistan • Myanmar

  9. ATS in E/SE Asia • Situation steadily worsening

  10. A. Detailed assessments: Regional Level: • East and Southeast Asia Country Level – 15 reports • Australia • Myanmar • Brunei • New Zealand • Cambodia • Philippines • China • Rep. of Korea • Indonesia • Singapore • Japan • Thailand • Lao PDR • Viet Nam • Malaysia B. Overviews: Launched: Nov 2010 • South Asia • Pacific Island States/Territories http://www.unodc.org/documents/eastasiaandpacific//2010/11/ats-2010-report-launch/ATS_Report_2010_web.pdf

  11. ATS: 9 things to worry about 1. Expanding ATS markets 2. Increasing ATS manufacture 3. Shift in precursor sourcing 4. Methamphetamine spillover from Myanmar 5. Increasing injecting use of methamphetamine 6. Lack of ATS treatment services 7. Increased Transnational Organized Crime activity 8. Ketamine use and trafficking is a growing concern 9. Harvesting and disposal of SRO problematic

  12. ATS: 9 things to worry about 1. Expanding ATS markets 2. Increasing ATS manufacture 3. Shift in precursor sourcing 4. Methamphetamine spillover from Myanmar 5. Increasing injecting use of methamphetamine 6. Lack of ATS treatment services 7. Increased Transnational Organized Crime activity 8. Ketamine use and trafficking is a growing concern 9. Harvesting and disposal of SRO problematic

  13. 1. Expanding ATS Markets ATS rank in the top 3 drugs of use in all countries Methamphetamine pills Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● ● ● ● 2 2 1 3 1 3 Ecstasy Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● ● ● 5 3 3 7 8 9 3 Crystalline methamphetamine Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● 1 1 2 2 3 1 3 7 3 ● = Not reported Source: DAINAP

  14. 1. Expanding ATS Markets ATS rank in the top 3 drugs of use in all countries Methamphetamine pills Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● ● ● ● 2 2 1 3 1 3 Ecstasy Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● ● ● 5 3 3 7 8 9 3 Crystalline methamphetamine Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● 1 1 2 2 3 1 3 7 3 ● = Not reported Source: DAINAP

  15. 1. Expanding ATS Markets ATS rank in the top 3 drugs of use in all countries Methamphetamine pills Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● ● ● ● 2 2 1 3 1 3 Ecstasy Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● ● ● 5 3 3 7 8 9 3 Crystalline methamphetamine Brunei Cambodia China Indonesia Lao PDR Malaysia Myanmar Philippines Singapore Thailand Viet Nam ● ● 1 1 2 2 3 1 3 7 3 ● = Not reported Source: DAINAP

  16. 1. Expanding ATS Markets Crystalline methamphetamine use trend, 2009 Use reported: 11 countries* Increasing: 6 China Indonesia Malaysia Singapore Thailand Viet Nam Decreasing: 3 Australia Brunei Darussalam Rep. of Korea Stable: 2 Japan New Zealand *Cambodia, Myanmar and the Philippines also reported crystalline methamphetamine use but did not report use trend data. Source: DAINAP

  17. ATS: 9 things to worry about 1. Expanding ATS markets 2. Increasing ATS manufacture 3. Shift in precursor sourcing 4. Methamphetamine spillover from Myanmar 5. Increasing injecting use of methamphetamine 6. Lack of ATS treatment services 7. Increased Transnational Organized Crime activity 8. Ketamine use and trafficking is a growing concern 9. Harvesting and disposal of SRO problematic

  18. 2. Increasing ATS manufacture • Manufacture or attempted manufacture in all but three countries • Small ‘kitchen type’ as well as large-scale laboratories seized • Slight decrease from 2008 but 80% increase from 2007 Jakarta, January 2009 Rizal province, Philippines, March 2009 Sources: DAINAP; BNN, 2010; PDEA, 2010

  19. 2. Increasing ATS manufacture Australia: • 316 labs seized (up 17% from 2008) Cambodia: • 5 labs and precursor manufacturing sites seized • Significant precursors and ephedra grass/seeds seized China: • 391* total labs seized (up 60% from 2008) Indonesia: • 37 labs seized (highest total on record) Sources: DAINAP; Global SMART data request forms, 2010; National reports; * Unclear if all were for ATS

  20. 2. Increasing ATS manufacture Japan: • Jun 2010: First lab reported since 1995 Myanmar: • Major producer of meth pills • 39 labs seized from 1998–2009 • Likelihood of large-scale labs New Zealand: • 135 labs seized • Large increase in precursor seizures Sources: DAINAP; Global SMART data request forms, 2010; National reports

  21. ATS: 9 things to worry about 1. Expanding ATS markets 2. Increasing ATS manufacture 3. Shift in precursor sourcing 4. Methamphetamine spillover from Myanmar 5. Increasing injecting use of methamphetamine 6. Lack of ATS treatment services 7. Increased Transnational Organized Crime activity 8. Ketamine use and trafficking is a growing concern 9. Harvesting and disposal of SRO problematic

  22. 4. Methamphetamine spillover from Myanmar • Major source of meth pills • 2009: 23.9 m meth pills seized • Most seizures near production centres • Seized pills primarily destined for neighbouring countries • 1998-2009: 39 small-scale facilities seized • Increased precursor seizures • No crystalline meth facility seized Source: DAINAP; CCDAC, 2009

  23. 4. Methamphetamine spillover from Myanmar 100,000,000 90,000,000 80,000,000 70,000,000 Seizures (pills) 60,000,000 50,000,000 40,000,000 30,000,000 20,000,000 10,000,000 0 2004 2005 2006 2007 2008 2009 2010* Note: Seizures from Australia and New Zealand are not included. • 2009: Total seizures 94 million pills (approx.) – 99% in China, Lao PDR, Myanmar and Thailand. • From 2008 to 2009: Three-fold increase (32m pills seized in 2008). Source: DAINAP

  24. 4. Methamphetamine spillover from Myanmar MYANMAR: Situation Assessment on Amphetamine-Type Stimulants Launched: 13 December 2010 http://www.unodc.org/documents/eastasiaandpacific//2010/12/ops-myanmar-ats/Myanmar_ATS_Report_2010_lowres.pdf

  25. Thanks to the following countries for funding SMART • Australia • Canada • Japan • Republic of Korea • New Zealand • Thailand

  26. Presentation Structure 1. Global situation 2. Amphetamine-Type Stimulants (focus on E/SE Asia) 3. Opiates • Afghanistan • Myanmar

  27. OPIATES: “Containment” • is working • but is under threat

  28. AFGHANISTAN http://www.unodc.org/documents/crop-monitoring/Afghanistan/Afghanistan_Opium_Survey_2010_web.pdf

  29. AFGHANISTAN • Cultivation = stable • Production = down

  30. 2010 123,000 2009 123,000 2008 157,000 2007 193,000 2006 165,000 Cultivation 2010 2005 104,000 2004 131,000 2003 80,000 2002 74,000 2001 8,000 2000 82,000 1999 91,000 1998 64,000 1997 58,000 1996 57,000 1995 54,000 1994 71,000 200,000 175,000 150,000 125,000 100,000 75,000 50,000 25,000 0 Hectares

  31. Poppy cultivation 2008–2010 (ha)

  32. Security and poppy cultivation

  33. Opium production 1994–2010 (mt)

  34. Affected opium crop in Helmand

  35. Affected stems and leaves of opium plant

  36. Presentation Structure 1. Global situation 2. Amphetamine-Type Stimulants (focus on E/SE Asia) 3. Opiates • Afghanistan • Myanmar

  37. South-East Asia: Opium Survey 2010 Launched: 13 December 2010 http://www.unodc.org/documents/eastasiaandpacific//2010/12/ops-myanmar-ats/SEA_Opium_Survey_report_2010_lowres.pdf

  38. CULTIVATION Lao PDR – up Myanmar – up Thailand – up

  39. CULTIVATION – SE Asia

  40. CULTIVATION – Global

  41. PRODUCTION Lao PDR – up = 16% global Myanmar – up production • increased Ha Thailand – up • increased yield

Recommend


More recommend